EDIT Editas Medicine, Inc.

Fundamentals / CIK 0001650664 / USD

Editas Medicine, Inc. reported $49.83M in revenue and a net loss of $72.22M for the trailing twelve months ended September 30, 2026 (up 37.4% year over year), with a -151.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open EDIT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$114.5M$57.23M$0-$229.4MFY 2016 Revenue: $6.05MFY 2016 Net Income: -$97.18M2016FY 2017 Revenue: $13.73MFY 2017 Net Income: -$120.3M2017FY 2018 Revenue: $31.94MFY 2018 Net Income: -$110.0M2018FY 2019 Revenue: $20.53MFY 2019 Net Income: -$133.7M2019FY 2020 Revenue: $90.73MFY 2020 Net Income: -$116.0M2020FY 2021 Revenue: $25.54MFY 2021 Net Income: -$192.5M2021FY 2022 Revenue: $19.71MFY 2022 Net Income: -$220.4M2022FY 2023 Revenue: $78.12MFY 2023 Net Income: -$153.2M2023FY 2024 Revenue: $32.31MFY 2024 Net Income: -$237.1M2024FY 2025 Revenue: $40.52MFY 2025 Net Income: -$160.1M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $40.52M $32.31M $78.12M $19.71M $25.54M $90.73M $20.53M $31.94M $13.73M $6.05M
Research & Development $89.95M $199.2M $177.7M $175.0M $142.5M $158.0M $96.90M $90.65M $83.16M $56.98M
Total Operating Expenses $200.5M $283.5M $247.3M $245.7M $218.7M $225.6M $161.5M $145.7M $133.7M $103.2M
Operating Income -$160.0M -$251.2M -$169.2M -$225.9M -$193.1M -$134.8M -$140.9M -$113.7M -$119.9M -$97.19M
EBITDA -$154.7M -$245.3M -$163.1M -$219.6M -$188.1M -$130.9M -$138.1M -$110.5M -$117.2M -$95.99M
Interest Expense $2.13M $0 -- -- -- -- -- -- -- --
Income Tax Expense $0 $0 $0 $0 $0 -- -- -- -- --
Net Income -$160.1M -$237.1M -$153.2M -$220.4M -$192.5M -$116.0M -$133.7M -$110.0M -$120.3M -$97.18M
Basic EPS -$1.80 -$2.88 -$2.02 -$3.21 -$2.85 -$1.98 -$2.68 -$2.33 -$2.98 -$3.02
Diluted EPS -$1.80 -$2.88 -$2.02 -$3.21 -$2.85 -$1.98 -$2.68 -$2.33 -$2.98 -$3.02
Basic Shares Outstanding 88.7M 82.3M 76.0M 68.7M 67.6M 58.6M 50.0M 47.1M 40.3M 32.2M
Diluted Shares Outstanding 88.7M 82.3M 76.0M 68.7M 67.6M 58.6M 50.0M 47.1M 40.3M 32.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $10.37M $11.89M $2.83M $24.74M $7.54M $3.58M $4.66M $30.60M
Research & Development $21.17M $20.18M $17.60M $27.40M $19.77M $16.18M $26.59M $48.61M
Total Operating Expenses $34.65M $30.44M $27.83M $32.50M $32.09M $55.12M $80.82M $77.20M
Operating Income -$24.28M -$18.55M -$25.00M -$7.75M -$24.55M -$51.54M -$76.16M -$46.59M
EBITDA -$23.90M -$18.14M -$24.52M -$6.95M -$23.83M -$49.71M -$74.25M -$45.21M
Interest Expense $0 $0 $5.00M $0 $0 $0 $2.13M $2.19M
Net Income -$23.39M -$18.23M -$24.98M -$5.62M -$25.12M -$53.23M -$76.09M -$45.40M
Basic EPS -$0.15 -$0.15 -$0.26 -- -$0.28 -$0.63 -$0.92 --
Diluted EPS -$0.15 -$0.15 -$0.26 -- -$0.28 -$0.63 -$0.92 --
Basic Shares Outstanding 153.6M 119.3M 97.9M -- 90.1M 84.4M 83.1M --
Diluted Shares Outstanding 153.6M 119.3M 97.9M -- 90.1M 84.4M 83.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $146.6M $131.5M $123.7M $141.5M $203.5M $139.7M $238.2M $134.8M $146.6M $185.3M
Short-Term Investments $0 $138.4M $199.5M $202.8M $296.3M $262.4M $219.0M $234.2M $182.5M --
Cash & Short-Term Investments $146.6M $269.9M $323.1M $344.3M $499.8M $402.1M $457.1M $369.0M $329.1M $185.3M
Accounts Receivable, Net $15.18M $16.27M $10.19M $5.14M $267K $6.05M $418K $30K $679K $88K
Total Current Assets $163.9M $289.3M $340.8M $356.8M $507.3M $419.1M $463.8M $374.8M $332.2M $187.2M
Property, Plant & Equipment, Net $3.54M $14.50M $12.03M $15.57M $17.12M $14.02M $10.89M $40.23M $39.44M $40.38M
Long-Term Investments -- $0 $104.0M $93.10M $120.1M $109.7M -- -- -- --
Other Non-Current Assets $2.98M $5.22M $8.59M $5.25M $6.81M $4.70M $5.39M $5.38M $1.62M $1.62M
Total Non-Current Assets $22.64M $52.27M $158.3M $157.6M $170.2M $153.5M $45.04M $45.61M $41.06M $42.00M
Total Assets $186.5M $341.6M $499.2M $514.3M $677.5M $572.6M $508.9M $420.4M $373.3M $229.2M
Accounts Payable $2.60M $5.49M $8.27M $9.51M $5.05M $6.41M $5.84M $5.33M $4.02M $4.64M
Short-Term Debt $5.00M $5.00M $0 -- -- -- -- -- -- --
Deferred Revenue (Current) $0 $6.22M $8.22M $8.22M $11.33M $20.94M $23.51M $15.71M $13.24M $256K
Other Current Liabilities -- -- -- -- -- -- $2.68M $2.05M $900K $748K
Total Current Liabilities $46.25M $77.22M $63.22M $60.11M $46.88M $58.21M $59.96M $35.90M $36.71M $33.08M
Long-Term Debt $53.60M $52.43M $0 -- -- -- -- -- -- --
Deferred Revenue (Non-Current) $44.51M $54.20M $60.67M $60.67M $60.89M $73.98M $163.2M $115.6M $94.72M $26.00M
Other Non-Current Liabilities $2.81M $3.07M $1.80M $0 -- $27.50M $1.0K $293K $317K $396K
Total Non-Current Liabilities $113.0M $130.1M $86.84M $93.53M $76.96M $120.8M $186.5M $148.3M $128.5M $61.49M
Total Liabilities $159.2M $207.3M $150.1M $153.6M $123.8M $179.0M $246.4M $184.2M $165.2M $94.58M
Total Debt (incl. Leases) $76.71M $92.47M $36.54M $43.95M $26.33M $26.14M $29.08M $32.42M -- --
Common Stock $10K $8.0K $8.0K $7.0K $7.0K $6.0K $5.0K $5.0K $4.0K $4.0K
Retained Earnings -$1.63B -$1.47B -$1.23B -$1.08B -$857.7M -$665.2M -$549.2M -$416.3M -$305.9M -$185.5M
Accumulated Other Comp. Income $0 $268K $198K -$3.60M -$493K -$46K $107K -$29K -$76K --
Total Stockholders' Equity $27.29M $134.3M $349.1M $360.7M $553.6M $393.6M $262.4M $236.2M $208.1M $134.6M
Total Equity $27.29M $134.3M $349.1M $360.7M $553.6M $393.6M $262.4M $236.2M $208.1M $134.6M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $93.17M $181.8M $123.6M $146.6M $165.6M $138.5M $138.7M $131.5M
Short-Term Investments $97.03M $29.83M -- $0 $0 $39.96M $82.27M $138.4M
Cash & Short-Term Investments $190.2M $211.6M $123.6M $146.6M $165.6M $178.5M $221.0M $269.9M
Accounts Receivable, Net $7.73M $2.73M $2.59M $15.18M $8.13M $588K $510K $16.27M
Total Current Assets $202.0M $218.1M $128.1M $163.9M $176.9M $182.8M $224.8M $289.3M
Property, Plant & Equipment, Net $2.19M $2.57M $2.88M $3.54M $4.29M $4.58M $8.18M $14.50M
Long-Term Investments -- -- -- -- -- -- -- $0
Other Non-Current Assets $2.98M $2.98M $2.98M $2.98M $2.99M $4.20M $4.20M $5.22M
Total Non-Current Assets $17.44M $19.30M $21.27M $22.64M $24.86M $27.79M $38.81M $52.27M
Total Assets $219.4M $237.4M $149.3M $186.5M $201.8M $210.6M $263.7M $341.6M
Accounts Payable $6.82M $4.74M $4.33M $2.60M $3.16M $6.72M $5.46M $5.49M
Short-Term Debt $7.50M $7.50M $7.50M $5.00M $5.00M $5.00M $5.00M $5.00M
Deferred Revenue (Current) $32.31M $32.31M -- $0 $0 $0 $2.00M $6.22M
Total Current Liabilities $71.58M $68.43M $39.78M $46.25M $61.77M $65.94M $73.11M $77.22M
Long-Term Debt $49.32M $48.24M $47.18M $53.60M $54.07M $51.67M $49.58M $52.43M
Deferred Revenue (Non-Current) $4.00M $4.00M $44.51M $44.51M $54.20M $54.20M $54.20M $54.20M
Other Non-Current Liabilities $2.56M $2.41M $2.87M $2.81M $4.69M $4.59M $6.36M $3.07M
Total Non-Current Liabilities $63.31M $63.65M $105.2M $113.0M $126.5M $125.5M $128.1M $130.1M
Total Liabilities $134.9M $132.1M $144.9M $159.2M $188.3M $191.4M $201.2M $207.3M
Total Debt (incl. Leases) $70.76M $71.25M $71.97M $76.71M $78.72M $77.81M $85.71M $92.47M
Common Stock $15K $15K $10K $10K $9.0K $9.0K $8.0K $8.0K
Retained Earnings -$1.70B -$1.67B -$1.65B -$1.63B -$1.62B -$1.60B -$1.54B -$1.47B
Accumulated Other Comp. Income -$96K -$6.0K $0 $0 $0 $15K $88K $268K
Total Stockholders' Equity $84.52M $105.3M $4.41M $27.29M $13.45M $19.19M $62.42M $134.3M
Total Equity $84.52M $105.3M $4.41M $27.29M $13.45M $19.19M $62.42M $134.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$160.1M -$237.1M -$153.2M -$220.4M -$192.5M -$116.0M -$133.7M -$110.0M -$120.3M -$97.18M
Depreciation & Amortization $5.28M $5.81M $6.06M $6.34M $5.05M $3.96M $2.83M $3.25M $2.68M $1.20M
Stock-Based Compensation $10.00M $21.42M $19.80M $29.29M $43.40M $23.16M $27.24M $26.60M $23.36M $16.88M
Change in Receivables $1.09M -$6.08M -$5.04M -$4.88M $5.78M -$5.63M -$388K $649K -$591K $931K
Change in Payables -$2.89M -$2.29M -$1.49M $4.37M -$1.14M $855K $274K $1.78M -$1.51M $3.25M
Operating Cash Flow -$165.2M -$210.3M -$132.2M -$177.3M -$163.8M -$179.8M -$40.67M -$45.71M -$9.42M -$50.25M
Capital Expenditure -$607K -$8.83M -$4.72M -$4.12M -$7.98M -$7.16M -$6.17M -$4.75M -$2.06M -$3.49M
Free Cash Flow -$165.8M -$219.1M -$136.9M -$181.5M -$171.8M -$187.0M -$46.84M -$50.46M -$11.48M -$53.74M
Purchases of Investments $0 -$86.22M -$258.5M -$315.2M -$408.9M -$458.4M -$342.2M -$459.4M -$375.3M --
Investing Cash Flow $138.7M $162.1M -$3.73M $114.1M -$54.47M -$140.5M $12.25M -$53.09M -$183.8M -$3.47M
Common Stock Issued $42.85M $0 $117.1M $0 $249.5M $203.7M $116.3M $76.79M $154.1M $97.49M
Financing Cash Flow $40.47M $56.03M $118.0M $1.28M $282.1M $224.1M $131.8M $86.94M $154.5M $97.16M
Net Change in Cash $13.90M $7.89M -$17.87M -$62.00M $63.84M -$96.24M $103.4M -$11.85M -$38.69M $43.44M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$23.39M -$18.23M -$24.98M -$5.62M -$25.12M -$53.23M -$76.09M -$45.40M
Depreciation & Amortization $385K $416K $483K $805K $721K $1.83M $1.92M $1.38M
Stock-Based Compensation $2.57M $2.19M $2.10M $2.13M $2.23M $2.66M $2.98M $4.02M
Change in Receivables -$5.00M -$133K $12.58M -$7.05M -$7.54M -$78K $15.76M -$16.14M
Change in Payables $2.54M -$58K $1.73M -$558K -$3.56M $1.26M -$27K -$7.00M
Operating Cash Flow -$21.19M -$29.57M -$23.06M -$36.39M -$30.84M -$50.21M -$47.80M -$50.76M
Capital Expenditure $0 -$106K -$92K -$60K -$433K $0 -$114K -$540K
Free Cash Flow -$21.19M -$29.67M -$23.15M -$36.45M -$31.28M -$50.21M -$47.91M -$51.30M
Purchases of Investments -- -- -- $0 $0 $0 $0 $4.0K
Investing Cash Flow -$66.99M -$29.80M $64K $58K $39.57M $42.65M $56.39M $30.96M
Common Stock Issued -$619K $117.5M $0 $17.08M $17.15M $7.18M $1.44M $0
Financing Cash Flow -$468K $117.5M $0 $17.33M $17.17M $7.41M -$1.44M $55.51M
Net Change in Cash -$88.65M $58.17M -$23.00M -$19.00M $25.90M -$150K $7.15M $35.71M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -394.9% -777.2% -216.6% -1146.3% -756.1% -148.6% -686.4% -356.1% -873.6% -1605.6%
Net Profit Margin -395.0% -733.7% -196.1% -1118.3% -753.6% -127.8% -651.4% -344.3% -876.5% -1605.5%
Return on Equity (ROE) -586.6% -176.6% -43.9% -61.1% -34.8% -29.5% -51.0% -46.6% -57.8% -72.2%
Return on Assets (ROA) -85.8% -69.4% -30.7% -42.9% -28.4% -20.3% -26.3% -26.2% -32.2% -42.4%
Current Ratio 3.54x 3.75x 5.39x 5.94x 10.82x 7.20x 7.74x 10.44x 9.05x 5.66x
Quick Ratio 3.50x 3.71x 5.27x 5.81x 10.67x 7.01x 7.63x 10.28x 8.99x 5.60x
Debt to Equity 2.81x 0.69x 0.10x 0.12x 0.05x 0.07x 0.11x 0.14x -- --
Revenue Growth (YoY) +25.4% -58.6% +296.3% -22.8% -71.8% +341.9% -35.7% +132.6% +126.8% --
5Y Revenue / Share Growth -70.5% -4.5% +51.7% -15.7% +101.1% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -151.7% -161.4% -281.3% -394.9% -428.7% -616.9% -726.4% -777.3%
Net Profit Margin -145.0% -157.3% -281.6% -395.0% -430.8% -608.9% -701.1% -733.7%
Return on Equity (ROE) -85.5% -70.2% -2471.7% -586.6% -1485.4% -1234.3% -402.5% -176.6%
Return on Assets (ROA) -32.9% -31.2% -73.0% -85.8% -99.1% -112.5% -95.3% -69.4%
Current Ratio 2.82x 3.19x 3.22x 3.54x 2.86x 2.77x 3.08x 3.75x
Quick Ratio 2.77x 3.13x 3.17x 3.50x 2.81x 2.72x 3.03x 3.71x
Debt to Equity 0.84x 0.68x 16.33x 2.81x 5.85x 4.05x 1.37x 0.69x
Revenue Growth (YoY) +37.4% +232.3% -39.2% -19.2% +12265.6% +597.5% +310.4% -49.0%
Source: SEC EDGAR CompanyFacts (CIK 0001650664) · from December 31, 2014 Data through September 30, 2026 · synced Nov 20, 2026, 05:38 UTC · Open in terminal